<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The aim of this study was to assess in an 11-year survival follow-up of a population-based cohort of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> the predictive role of World Health Organization-defined <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, independent of conventional <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: During the follow-up (1991-2001), 1,565 patients were regularly examined with centralized measurements of HbA(1c) </plain></SENT>
<SENT sid="2" pm="."><plain>The independent role of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> as a predictor of <z:hpo ids='HP_0000001'>all</z:hpo>-cause and cardiovascular mortality was assessed with multivariate Cox proportional hazards modeling </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: At baseline, the prevalence of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> was 75.6% (95% CI 73.6-77.9) </plain></SENT>
<SENT sid="4" pm="."><plain>Results are based on 685 <z:hpo ids='HP_0011420'>deaths</z:hpo> (520 with the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and 165 without it) in 10,890.2 person-years of observations </plain></SENT>
<SENT sid="5" pm="."><plain>With respect to subjects without the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, those with the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> had a similar hazard ratio (HR) of cardiovascular mortality after adjustment for age, sex, smoking, total cholesterol level, and <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>In contrast, relative to subjects with <z:mp ids='MP_0002055'>diabetes</z:mp> only, the HR of subjects with only one component of the syndrome was 2.92 (1.16-7.33), independent of other risk factors </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: We found that 1) the prevalence of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> in a population-based cohort of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is high (75.6%); 2) the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> is not a predictor of 11-year <z:hpo ids='HP_0000001'>all</z:hpo>-cause and cardiovascular mortality; and 3) more than twofold higher cardiovascular risk, independent of conventional risk factors, is evident in diabetic subjects with only one component of the syndrome compared with those with <z:mp ids='MP_0002055'>diabetes</z:mp> only </plain></SENT>
<SENT sid="8" pm="."><plain>Categorizing type 2 diabetic subjects as having or not having the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> does not provide further prediction compared with the knowledge of its single components </plain></SENT>
</text></document>